Comparison of 18F-Fluoroerythronitroimidazole and 18F-Fluorodeoxyglucose Positron Emission Tomography and Prognostic Value in Locally Advanced Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Comparison of 18F-Fluoroerythronitroimidazole and 18F-Fluorodeoxyglucose Positron Emission Tomography and Prognostic Value in Locally Advanced Non–Small-Cell Lung Cancer

Published:2010-09 Issue:5 Volume:11 Page:335-340
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Li Ling,Hu Man,Zhu Hui,Zhao Wei,Yang Guoren,Yu Jinming

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference36 articles.

1. Role of 18F-FDG PET in assessment of response in non–small-cell lung cancer;Hicks;J Nucl Med,2009

2. Imaging of hypoxia in human tumors with (F-18) fluoromisonidazole;Koh;Int J Radiat Oncol Biol Phys,1992

3. Comparison of the biodistribution of two hypoxia markers F-18 FETNIM and F-18 FMISO in an experimental mammary carcinoma;Grönroos;Eur J Nucl Med Mol Imaging,2004

4. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis;Avril;J Nucl Med,2001

5. Dependence of FDG uptake on tumour microenvironment;Pugachev;Int J Radiat Oncol Biol Phys,2005

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia predicts favorable response to carbon ion radiotherapy in non-small cell lung cancer (NSCLC) defined by 18F-FMISO positron emission tomography/computed tomography (PET/CT) imaging;Quantitative Imaging in Medicine and Surgery;2024-05

2. NF-κB in the Radiation Response of A549 Non-Small Cell Lung Cancer Cells to X-rays and Carbon Ions under Hypoxia;International Journal of Molecular Sciences;2024-04-19

3. Hypoxia A Typical Target in Human Lung Cancer Therapy;Current Protein & Peptide Science;2023-11-29

4. A Role of Non-FDG Tracers in Lung Cancer?;Seminars in Nuclear Medicine;2022-11

5. Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose;Frontiers in Medicine;2022-10-05